(
233
Results
)
Filter
Only match titles
What are you looking for?
-
Category
-
Type
-
Year
-
Keywords
-
Author
Apply filters
Knowledge Hub
Collapse
-
Advances in understanding allergen immunotherapy, drug and food allergy
-
Are children just little adults in the drug allergy diagnostic work up?
-
Biological severe asthma treatment in Poland – pros and cons of drug programme
-
Drug allergy – time for a personalised approach
-
EAACI & AAAAI joint symposium: hot topics in drug hypersensitivity
-
Flash Talkson drug allergy
-
Flash talks on drug allergy I
-
Flash talks on drug allergy II
-
How to classify cutaneous manifestations of drug hypersensitivity
-
Management of drug allergy
-
Metabolic changes in the prediction of severe anaphylactic reactions
-
Oral food challenges thresholds for clinical reactions
-
Predicting adverse reactions to biologicals
-
Recognizing immediate reactions in contact dermatitis
-
Severe cutaneous allergic reactions: searching for the culprit drug
-
Update on drug allergy
-
Update on practical approaches in delayed drug hypersensitivities
-
Which skin tests can be used for delayed cutaneous adverse drug reactions?
Show more Event Resources (16)Show Less-
-
A EAACI drug allergy interest group survey on how European allergy specialists deal with β-lactam allergy
-
ARIA-EAACI statement on severe allergic reactions to COVID-19 vaccines – an EAACI-ARIA Position Paper
-
An EAACI position paper on the investigation of perioperative immediate hypersensitivity reactions
-
Comparing biologicals and small molecule drug therapies for chronic respiratory diseases: An EAACI Taskforce on Immunopharmacology position paper
-
EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivity
-
EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccines
-
EAACI/ENDA Position Paper: Diagnosis and management of hypersensitivity reactions to non-steroidal anti-inflammatory drugs (NSAIDs) in children and adolescents
-
EAACI/ENDA position paper on drug provocation testing
-
Flow-based basophil activation test in immediate drug hypersensitivity. An EAACI task force position paper
-
Genetic variants associated with T cell-mediated cutaneous adverse drug reactions: A PRISMA-compliant systematic review – An EAACI position paper
-
Hypersensitivity reactions to biological agents: An EAACI position paper
-
Hypersensitivity reactions to chemotherapy: an EAACI position paper
-
Hypersensitivity reactions to proton pump inhibitors. An EAACI position paper
-
The urgent need for a harmonized severity scoring system for acute allergic reactions
-
Diagnosis and management of the drug hypersensitivity reactions in coronavirus disease 19: An EAACI position paper
Show more Position Papers (13)Show Less-
-
Burden of hypersensitivity reactions to biologics
-
Challenges in Drug Allergy
-
Diagnosis and management of hypersensitivity reactions due to biologics
-
Diagnosis of Drug Allergy
-
Introduction to the Drug Allergy Modules
-
Management of Common Drug Allergies
-
Pitfalls of hypersensitivity reactions due to biologics
-
Introduction to the Drug Hypersensitivity Module: Update in hypersensitive reactions to biologicals
Show more Courses (6)Show Less-
-
Management of adverse reactions to anticoagulants
-
Recommendations for prevention and management of adverse reactions to biologics
-
Update in the classification of hypersensitivity reactions to non-steroidal anti-inflammatory drugs
-
Updated guidelines on the risk assessment and methodology of skin tests for the investigation of drug allergy
-
Clinical diagnosis and management of severe cutaneous adverse drug reactions (SCARs) in children: an ENDA/EAACI pediatric task force report
-
Mechanisms and biomarkers involved in Drug Hypersensitivity Reactions
Show more Task Forces (4)Show Less-
-
ARIA‐EAACI statement on severe allergic reactions to COVID‐19 vaccines – an EAACI‐ARIA position paper
-
Allergic reactions to the first COVID‐19 vaccine: a potential role of polyethylene glycol?
-
EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID‐19 vaccines
Show more Covid-19 (1)Show Less-
-
ARIA-EAACI statement on severe allergic reactions to COVID-19 vaccines – an EAACI-ARIA position paper
-
EAACI/ENDA Position Paper: Diagnosis and management of hypersensitivity reactions to non-steroidal anti-inflammatory drugs (NSAIDs) in children and adolescents
-
EAACI/ENDA position paper on drug provocation testing
Show more Consensus Documents (1)Show Less-
Website
Collapse
-
“In Class Cross-Reactivity” to all tested cephalosporins revealed in a patient with Cefazolin-induced Severe Cutaneous Adverse Drug Reaction
-
A Retrospective Analysis of Drug Provocation Tests in Children with Underlying Conditions
-
A case of progestogen hypersensitivity with reactions to endogenous progesterone and exogenous progestins
-
A rare case of IgE-mediated multiple drug hypersensitivity syndrome
-
Absence of alpha-tryptase isoforms is associated with less severe allergic reactions at food challenge to peanut
-
Advances in drug allergy diagnosis and management
-
Adverse reactions to biologicals in severe asthma
-
Adverse reactions to iodinated contrast media in a tertiary hospital
-
Aeroallergen sensitization in beekeepers and systemic reactions to bee venom
-
Allergic concerns in the probiotic era: a closer look at Actimel® reactions
-
Allergic reactions in school. Action protocols and legal framework
-
Always in the same location. A pediatric fixed drug eruption case.
-
An eleven-year experience with drug desensitization at a fourth level center in Colombia
-
Analysis of all allergy and hypersensitivity reactions to anti-COVID19 vaccines according to the EUDRA Vigilance database
-
Analysis of all allergy and hypersensitivity reactions to anti-COVID19 vaccines according to the EUDRA Vigilance database
-
Analytical testing of PQ Grass allergoid drug product using antibodies
-
Anaphylaxis after drug provocation test with iohexol
-
Anaphylaxis and drug allergy
-
Are large local reactions an indication for immunotherapy?
-
Artificial Intelligence approaches for advancing drug development and clinical applications
-
Assessing Beta-Lactam Skin Testing: Rediscovering Systemic Reactions
-
Atypical clinical cases of fixed drug eruptions due to radiological contrast media
-
Biomarker-driven drug development for allergic diseases
-
Biphasic Anaphylactic Reactions Following Lentils Ingestion
-
Blame the drug or the additive?
-
Carbamazepine induced Drug reaction with eosinophilia and systemic symptoms (DRESS) with cross-reactivity to lamotrigine confirmed by a positive rechallenge
-
Clinical Evolution Of Adults Diagnosed of Hypersensitivity Reactions To NSAIDs
-
Clinical Evolution Of Adults Diagnosed of Hypersensitivity Reactions To NSAIDs
-
Clinical Evolution Of Children Diagnosed of Hypersensitivity Reactions To NSAIDs
-
Clinical Evolution Of Children Diagnosed of Hypersensitivity Reactions To NSAIDs
-
Clinical history seen with different hypersensitivity reactions
-
Clinical phenotypes of nonsteroidal anti-inflammatory drug hypersensitivity
-
Co-existing Histamine Intolerance and Shrimp Allergy in Subjects with Adverse Reactions Following Shrimp Ingestion
-
Controversies in Drug Provocation Tests
-
Current understanding of nonsteroidal anti-inflammatory drug hypersensitivity
-
Decoding adverse reactions to contrast media: a comprehensive study from Chile
-
Delayed drug hypersensitivity to bortezomib: an effective desensitization
-
Delayed hypersensitivity reactions to non steroidal anti-inflammatory drugs : a cases study
-
Desensitization Protocol for Cemiplimab Immediate Hypersensitivity Reactions due to Cytokine Release in Lung Cancer: Report of 2 cases
-
Differential diagnosis of Drug allergy
-
Direct drug provocation test with beta-lactams in children and adolescents
-
Drug Allergy
-
Drug Allergy: Today and Tomorrow
-
Drug Reaction With Eosinophilia and Systemic Symptoms: Deciphering the diversity of systemic immune profiles
-
Drug Reaction With Eosinophilia and Systemic Symptoms: Deciphering the diversity of systemic immune profiles
-
Drug allergy
-
Drug allergy
-
Drug allergy – Session 1: Diagnosis
-
Drug allergy 1
-
Drug allergy 2
-
Drug allergy 3
-
Drug allergy 4
-
Drug allergy 5
-
Drug allergy 6
-
Drug allergy 7
-
Drug allergy 8
-
Drug allergy severity and quality of life: Data from the BIOGRIAL study
-
Drug desensitization in pediatric patients – A challenging, effective and safe approach
-
Drug provocation test to acetyl salicylic acid in a children cohort
-
Drug provocation tests with beta-lactam – from suspicion to confirmation
-
Drug provocation tests: which protocol to follow?
-
Drug reaction with eosinophilia and systemic symptoms (DRESS) caused by bortezomib and trimethoprim/sulfamethoxazole
-
Drug reaction with eosinophilia and systemic symptoms (DRESS) concomitant to SARS cov2 infection induced by sulfasalazine with a relapse to mesalasine
-
Drug reaction with eosinophilia and systemic symptoms (DRESS): clinical manifestations and prognostic factors associated with disease severity
-
Drug reaction with eosinophilia and systemic symptoms (DRESS): clinical manifestations and prognostic factors associated with disease severity
-
Drug – induced anaphylaxis in childhood
-
Drug-induced bullous drug eruptions: a case series
-
EAACI position paper about basophil activation test in immediate drug hypersensitivity
-
Early inflammatory reactions in mice after immunotherapy with an allergen microcrystalline tyrosine adsorbate
-
Evaluation of risk factors causing diagnostic delay in non-steroidal anti-inflammatory drug -exacerbated respiratory disease
-
Exploring Drug Hypersensitivity in Pediatric Patients with Chronic Spontaneous Urticaria: ‘’A Comprehensive Analysis Using Diagnostic Tests”
-
Factors associated with severity of reactions during oral food challenge test
-
Ferric Carboxymaltose Hypersensitivity Reactions
-
Fixed Drug Eruption to aminopenicillins: a case series
-
Fixed drug eruption caused by etoricoxib with tolerance to celecoxib and parecoxib
-
Fixed drug eruption caused by lansoprazole
-
Fixed drug eruption caused by lansoprazole
-
Fixed drug eruption due to Levofloxacin
-
Flash talks on Drug Allergy 1
-
Flash talks on Drug Allergy 2
-
Flow cytometric based lymphocyte activation test measuring CD69 upregulation by an absolute count-based T-cell analysis in patients with delayed-type reactions to beta-lactam antibiotics
-
Flow cytometric based lymphocyte activation test measuring CD69 upregulation by an absolute count-based T-cell analysis in patients with delayed-type reactions to beta-lactam antibiotics
-
Food hypersensitivity reactions in adults: A longitudinal cohort study
-
Food oral immunotherapy monitoring with OITcontrol® is related to reduced number of home adverse reactions and better treatment compliance compared with paper-based monitoring
-
Food oral immunotherapy monitoring with OITcontrol® is related to reduced number of home adverse reactions and better treatment compliance compared with paper-based monitoring
-
Food-specific IgE antibody reactions and self-reported symptomatology in Spanish adults
-
Frequency and severity of allergic reactions to non-mandatory labelled food allergens – a data analysis from the Anaphylaxis Registry and the EuroPrevall outpatient clinic study
-
Frequency of Long-Term Development of Nonsteroidal Anti-Inflammatory Drug (NSAID) Hypersensitivity in Patients who Underwent Nasal Polypectomy during Childhood
-
Generalised fixed drug eruption induced by propofol: A rare case of delayed type IV hypersensitivity reaction
-
Glutathione peroxidase single nucleotide polymorphisms associated with nonsteroidal anti-inflammatory drug hypersensitivity-induced urticaria/angioedema
-
How and when to perform skin tests for possible drug allergy
-
Hymenoptera venom immunotherapy with 210 minutes Ultra-Rush protocol: patient profile and potential risk factors for systemic reactions
-
Hypersensitivity Reactions to Contrast Media: Reality from a Portuguese Tertiary Hospital
-
Hypersensitivity Reactions to Oxaliplatin and Carboplatin: Clinical Features and Cross Reactivity
-
Hypersensitivity reactions in biologicals
-
Hypersensitivity reactions to Proton pump inhibitors: Patterns of cross- reactivity in a Tunisian series
-
Hypersensitivity reactions to xanthine oxidase inhibitors: Facts or myths ?
-
INTERESTING FACT: Delayed systemic allergic reactions to corticosteroids: Clinical symptoms y cross-reactivity
-
Identifying the most at-risk age-group and longitudinal trends of drug allergy labelling among 7.3 million individuals in Hong Kong
-
Immediate Hypersensitivity Reactions to Proton Pump Inhibitors – diagnostic workup
-
Immediate hypersensitivity reactions to corticosteroids: Clinical symptoms and cross-reactivity
-
Impact of the drug allergy challenges’ outcome on children and parents
-
Incidence of Perioperative Hypersensitivity Reactions in Spanish Hospital Cohorts – A Two-Year investigation (2022-2023)
-
Incidence of Perioperative Hypersensitivity Reactions in the Allergy-Anaesthesia Unit of Hospital Central Cruz Roja. Tree-year study
-
Innovation Hub 5 – Application of Artificial Intelligence in drug discovery: the bigger picture
-
Innovation in drug allergy education: partnerships and potential across the Asia Pacific and beyond
-
Intraoperative anaphylactic reactions by metamizole
-
Knowledge, Attitude, and Practice of Pediatric Drug Allergy among Medical Interns: A Cross-Sectional Study
-
Long-term outcomes of drug reaction with eosinophilia and systemic symptoms: a ten-year prospective study from a tertiary center
-
Lymphocyte transformation test in the diagnosis of DRESS Syndrome: What criteria are most effective in determining drug causality?
-
Management decisions in 13 patients with hypersensitivity reactions to chemotherapy agents
-
Management of adverse reactions to platinum based drugs in our unit in the last year
-
Management of reactions to chemotherapeutic drugs in children
-
Modified Peanut Allergen mRNA Induces Cross-Blocking Antibodies that Protect Against Allergic Reactions in an in-vivo Allergy Model
-
Multidisciplinary approach in drug allergy
-
Multiple Fixed Drug Eruption with Arylpropionics and Nolotil: A Case Report
-
Multiple detection of IgE-mediated Food reactions using Microarray technology
-
Navigating Oral Food and Drug Provocation Tests: Assessing Tolerance and Safety in Clinical Settings
-
Novel Approaches for Drug Allergy
-
Novel analytical tool supporting drug development and biomarker discovery: The era of machine learning in Allergy and Immunology
-
OAS2 – Drug and Skin Allergy
-
Our experience with rapid desensitisation in delayed hypersensitivity reactions to biological drugs
-
PDS12: Drug Allergy
-
Paracetamol-induced fixed drug eruption: A case Series
-
Pediatric Drug Hypersensitivity
-
Pediatric drug desensitizations: National experience
-
Perioperative Hypersensitivity Reactions in a Spanish Hospital Group
-
Placebo and nocebo responses in drug allergy
-
Poloxamer formulation for allergen immunotherapy reduces systemic allergic reactions in a mouse model
-
Predictive factors of breakthrough reactions during desensitization for oncological treatments
-
Prognostic markers for drug challenges in non-steroidal anti-inflammatory drugs
-
Prognostic markers for drug challenges in non-steroidal anti-inflammatory drugs
-
Rapid drug desensitization to taxanes: a descriptive study from Turkey
-
Reactions Due to Accidental Peanut Consumption During Epicutaneous Immunotherapy for Peanut Allergy in Toddlers
-
Reflection on the Role of Basophil Activation Test in the Diagnosis of Pediatric Drug Allergy
-
Related factors to cefazolin perioperative hypersensitivity reactions
-
Relevance of Administration Route in Immediate Hypersensitivity Reactions to Fluoroquinolones
-
Retrospective Analysis of Fixed Drug Eruptions: Unveiling Clinical Patterns and Identifying Causative Drugs
-
Retrospective evaluation of the PEN-FAST tool in Patients Undergoing Prolonged Drug Provocation
-
Retrospective evaluation of the PEN-FAST tool in Patients Undergoing Prolonged Drug Provocation
-
Retrospective observational study on longitudinal trends in the severity of adverse reactions in paediatric acute Food Protein-Induced Enterocolitis Syndrome (FPIES). (Grade-severity of Recurrence of Acute FPIES – GRAF Study)
-
Riddles of drug hypersensitivity diagnosis: a case series
-
Risk Factors in Breakthrough Reactions during Monoclonal Antibody Desensitization
-
Risk factors for reactions in desensitization to penicillin of pregnant women with syphilis: a Flow chart suggestion
-
Safety of a Three-Step Provocation Test in Mild Hypersensitivity Reactions to Beta-Lactams
-
Safety of direct and single-dose drug provocation test in low-risk penicillin allergy labels
-
Should we perform prolonged drug provocation routinely?
-
Simultaneous double drug provocation test in a low risk patient to refute unlikely allergy to paracetamol and ibuprofen
-
Subcutaneous immunotherapy with a depigmented cat allergoid in patients with cat allergy is safe and results primarily in delayed local reactions
-
Successful Desensitization with CFTR Modulatory Drugs in Delayed Cutaneous Hypersensitivity Reactions
-
Successful Rapid Desensitization in a Patient with Metastatic Colorectal Cancer Presenting with Regorafenib-Mediated Fixed Drug Eruption
-
Systemic allergic reactions to subcutaneous allergen immunotherapy – A single center experience
-
The First Case Report of 12-Step 3-Bag Successful Rapid Drug Desensitization to Daratumumab in a Patient with Renal Failure Due to Secondary Systemic Amyloid and Plasma Cell Dyscrasia
-
The challenge of drug allergy: A revised nomenclature for allergic diseases is required
-
The use of risk assessment in drug allergy
-
Therapeutic drug monitoring of 6-thioguanine nucleotides
-
Twenty-Five Years’ Experience with Immediate-Type Local Anesthetic Reactions in Children
-
Visiting the emergency room with a drug allergy label. Our experience in real life
-
Which skin tests can be used for delayed cutaneous adverse drug reactions?
-
Adverse reactions to biologicals:in vivo allergy tests as a reliable tool in hypersensitivity reactions to erenumab
-
Analysis of adverse drug reactions to iodinated contrast media in a tertiary hospital: A 9-year experience
-
Drug Hypersensitivity Reactions In A Pediatric Population Before And After COVID-19 Pandemic – A Retrospective Study In A Portuguese Hospital Center
-
Drug allergy – Session 2: Precision medicine in drug allergy
-
Drug provocation using two equal doses in patients with suspected drug allergy
-
Early Use Of Intravenous Methylprednisolone Attenuates Positive Challenge Reactions During Sequential Additive Drug Challenge
-
First-line anti-tuberculosis drug challenge reactions in DRESS in an HIV endemic setting
-
Initial Drug Provocation Test with acetylsalicylic acid is less time consuming for the diagnosis of Hypersensitivity Reactions to Non-Steroidal Anti-Inflammatory drugs in pediatric age
-
Initial Drug Provocation Test with acetylsalicylic acid is less time consuming for the diagnosis of Hypersensitivity Reactions to Non-Steroidal Anti-Inflammatory drugs in pediatric age
-
Safety of Single-Dose Drug Provocation Test in Low Risk Non-Immediate Reactions with Beta-Lactam Antibiotics in Children
-
Successful rapid drug desensitization with adrenaline infusion pump in severe allergic reactions
-
The importance of the drug provocation test as a diagnostic tool in immediate hypersensitivity reactions to chemotherapeutics
-
The importance of the drug provocation test as a diagnostic tool in immediate hypersensitivity reactions to chemotherapeutics
-
Variability in the genes involved in the cellular redox status, and their association with drug hypersensitivity reactions to nonsteroidal anti-inflammatory drugs and ß-lactam antibiotics
-
Assessment of the Impact of Drug Provocation Testing on Anxiety in Patients Experiencing Drug Hypersensitivity Reactions
-
Assessment of the Impact of Drug Provocation Testing on Anxiety in Patients Experiencing Drug Hypersensitivity Reactions
-
Adverse drug reactions to taxanes: positive skin testing correlates with breakthrough reactions during drug desensitisation
Show more Sessions (174)Show Less-